The reduction of AP-induced abdominal hyperalgesia by the treatment with HEVm may be a consequence of the decrease of pancreatic inflammatory mediators, such as TNF-α, IL-1β, and IL-6. The gene discussed is IL6; the disease is alkaline phosphatase measurement.